Published in Am J Ophthalmol on December 01, 2002
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol (2010) 1.45
Glaucoma management: relative value and place in therapy of available drug treatments. Ther Adv Chronic Dis (2014) 0.87
Recent advances in pharmacotherapy of glaucoma. Indian J Pharmacol (2008) 0.83
Clinical options for the reduction of elevated intraocular pressure. Ophthalmol Eye Dis (2012) 0.79
Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study. Clin Ophthalmol (2017) 0.75
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol (2003) 4.35
Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure. Ophthalmology (2004) 1.29
Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States. J Glaucoma (2005) 0.78
Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina (2016) 0.77
Efficacy of trabecular bypass stent through 2 years: data from the United States pivotal trial. J Cataract Refract Surg (2014) 0.76
A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy. BMC Ophthalmol (2011) 0.75
Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine. J Clin Psychopharmacol (2003) 0.75
The current state of corneal reshaping. Eye Contact Lens (2005) 0.75